}
  • Home   ›
  •   Indian Tenders   › Tender Notice : 22672459

    • Supply Of Medical Store(Drugs), ARMY HOPSITAL R AND R DELHI CANTT-10-Delhi

    Indian Army-IA has published Supply Of Medical Store(Drugs). Submission Date for this Tender is 03-12-2019. Medicine Tenders in ARMY HOPSITAL R AND R DELHI CANTT-10 Delhi. Bidders can get complete Tender details and download the document.




    Tender Notice

    22672459
    Supply Of Medical Store(Drugs)
    Open Tender
    Indian
    Delhi
    ARMY HOPSITAL R AND R DELHI CANTT-10
    03-12-2019

    Tender Details

    Supply Of Medical Store ( Drugs ) :-E / D Brimonidine Tartarate 0 . 15% With Stabilized Oxychloro Complex Usfda Approved , E / D Travaprost 0 . 004% + Timolol Maleate 0 . 5% Drop Tainer System 2 . 5 Ml , E / D Moxifloxacin Hcl 0 . 5%In Ldfe Bottle Inactive Ingredients Boric Acid Nacl , Hcl & Naoh To Adjust Ph , Isotonic Solution With Osmolality Of 290 Mosm / Kg , Us Fda Approved With Drop Tainer System , E / D Sodium Hyaluronate 0 . 1% , 10 Ml Bottle , In Comod System , E / D Olopatadine Hcl 0 . 2% , Cyanoacrylate Glue For Ocular Use , Contains Vial With Syringe For Application , Tissue Adhesive Fibrin Glue 1 Ml Kit , Inj Chondroitin Sodium 40 Mg , Sodium Hyaluronate 30 Mg , 0 . 75 Ml Preloaded Syringe With Cannula ( Sterile ) , Inj Verteporfin 15 Mg ( Visudyne ) Single Use Glass Vial With Grey Bromobutyl Stopper And Aluminium Flippoff Cap , Inj Dexamethasone Intravitreal Implant 0 . 7 Mg Biodegradable Approved By Usfda Preloaded With The Applicator , Sterile , Inj Aflibercept 2 Mg / 0 . 05Ml For Intraocular Use , Inj Silicone Oil 1000Cs Prefilled Usfda Approved Must Not Contain Any Bubbles And Must Not Disconnect From Tubing During Injection Should Not Emulsify With In 3 Months . Emulsification With In 3 Months Will Result In Rejection . No Fibrin Should Be Seen On Post Op Day 01 , Cap Ibrutinib 140Mg ( Bottle Of 90 Cap ) , Third Generation Recombinant Factor Viii 1500 Iu , Third Generation Recombinant Factor Viii 500 Iu , Tab Dasatinib 20 Mg ( Bottle Of 60 Tabs ) , Inj Ranibizumab 2 . 3Mg / 0 . 23 Ml . The Shelf Life Should Be 03 Years As Specified In Pvms List , Inj Bevacizumab 100Mg / 4Ml Vial , Pantaprazole 40 Mg Tab

    Key Value

    Document Fees
    Refer document
    EMD
    INR 2256062.0 /-
    Tender Value
    INR 4.51 Crore /-

    BOQ Items

    Name of Work: Supply of Med Store(Drugs)
    Sl. No. Item Description Item Code / Make Quantity Units
    1 1 Med Store(Drugs)
    2 1.01 E/D Brimonidine tartarate 0.15% with stabilized oxychloro complex USFDA approved item1 8730 Bott
    3 2.01 E/D Travaprost 0.004% + timolol Maleate 0.5% drop tainer system 2.5 ml item2 2970 Bott
    4 3.01 E/D Moxifloxacin HCL 0.5%in LDFE bottle inactive ingredients Boric acid Nacl, HCL & NaOH to adjust pH, Isotonic solution with osmolality of 290 mOsm/kg, US FDA approved with drop tainer system item3 5547 Bott
    5 4.01 E/D Sodium hyaluronate 0.1%, 10 ml bottle, in COMOD system item4 1980 Bott
    6 5.01 E/D Olopatadine HCL 0.2% item5 1980 Bott
    7 6.01 CYANOACRYLATE GLUE for ocular use, contains vial with syringe for application item6 111 KIT
    8 7.01 TISSUE ADHESIVE FIBRIN GLUE 1 ML KIT item7 210 No
    9 8.01 Inj Chondroitin sodium 40 mg, Sodium hyaluronate 30 mg, 0.75 ml preloaded syringe with cannula (sterile) item8 390 Prefilled Vial
    10 9.01 Inj Verteporfin 15 mg(Visudyne) single use glass vial with grey bromobutyl stopper and aluminium flippoff cap item9 45 Vial
    11 10.01 Inj Dexamethasone intravitreal implant 0.7 mg biodegradable approved by USFDA preloaded with the applicator, sterile item10 180 No
    12 11.01 Inj Aflibercept 2 mg/0.05ml for intraocular use item11 150 Vial
    13 12.01 Inj Silicone oil 1000cS prefilled USFDA approved must not contain any bubbles and must not disconnect from tubing during injection should not emulsify with in 3 months. Emulsification with in 3 months will result in rejection. No fibrin should be seen on post op day 01 item12 450 Vial
    14 13.01 Cap Ibrutinib 140mg (bottle of 90 Cap) item13 1140 Bottle
    15 14.01 Third Generation Recombinant Factor VIII 1500 IU item14 150 Vial
    16 15.01 Third Generation Recombinant Factor VIII 500 IU item15 300 Vial
    17 16.01 Tab Dasatinib 20 mg (bottle of 60 tabs) item16 1320 Nos
    18 17.01 Inj Ranibizumab 2.3mg/0.23 ml. The shelf life should be 03 years as specified in PVMS list item17 165 No
    19 18.01 Inj Bevacizumab 100mg/4ml vial item18 286 Vial
    20 19.01 Pantaprazole 40 mg Tab item19 60000 No
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail